Value Added Technology Co (043150) Fair Value & Analysis
Healthcare · KR · Market cap 259B KRW
Fair value as of: Jul 20, 2026
From 24 valuation models · updated 21 days ago
Share price +9.1% over the past month.
A solid business, screening 205% undervalued on our models.
What matters now
- The price is below even our cautious bear case (45,181 KRW). The market is more pessimistic than our downside scenario.
- Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 16,330 KRW – 44,881 KRW · fair‑value band 45,181 KRW – 75,302 KRW · the 19,740 KRW price screens below the 60,242 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Value Added Technology Co (043150) currently trades at 19,740 KRW, while our model-based Fair Value estimate is 60,242 KRW, implying the stock looks roughly 205.2% undervalued today. The Quality Score stands at 66/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Value Added Technology Co generated revenue of 388B KRW at a net margin of 17.6%. Revenue grew 19.1% year over year. Fundamentals as of Jul 20, 2026
Our scenario range runs from 45,181 KRW (bear case) to 75,302 KRW (bull case); at 19,740 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -11% fair-value upside, at 205%, 043150 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (76,033 KRW) versus Asset-Based (22,664 KRW). Highest evidence: Growth DCF (80).
Notify me when 043150 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 33
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Value Added Technology Co., Ltd. develops, manufactures, and sells dental medical X-ray devices in Korea. It offers 2D, 3D, and intra oral imaging products. The company was founded in 1992 and is headquartered in Hwaseong, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Value Added Technology Co reported revenue of 426B KRW in FY2025 versus 339B KRW in FY2021, a compound +5.9%/yr. Reported net income was 40.1B KRW in FY2025, compounding −5.9%/yr from FY2021.
Watch 043150: get an alert when its fair value changes →
Peer Group
Health Care · 2227 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)
Valuation Multiples vs Health Care median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 50,900 KRW | 49,984 KRW | -2% |
| i-SENS, Inc 099190 | 15,270 KRW | 8,168 KRW | -47% |
| Mediana Co 041920 | 8,940 KRW | 6,289 KRW | -30% |
| Meta Biomed Co 059210 | 3,830 KRW | 9,875 KRW | +158% |
| Sewoon Medical Co 100700 | 2,245 KRW | 6,054 KRW | +170% |
| MEDIC MEDIC | 0.2100 PHP | 0.1400 PHP | -33% |
| MEKICS CO., Ltd 058110 | 1,780 KRW | 1,584 KRW | -11% |
| CU Medical Systems, Inc 115480 | 1,753 KRW | 1,134 KRW | -35% |
| PeopleBio, Inc 304840 | 857.00 KRW | 905.70 KRW | +6% |
| Novartis AG NVSN | 2,742 MXN | 2,379 MXN | -13% |
Compare Value Added Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Value Added Technology Co (043150) overvalued or undervalued?
What is the fair value of 043150?
What is the quality score of 043150?
What is the revenue of Value Added Technology Co (043150)?
What is the net profit margin of 043150?
Does Value Added Technology Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Value Added Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.